CVI Investments, Inc. 13D/13G Filings for Cyclacel Pharmaceuticals, Inc. (CYCC)

CVI Investments, Inc. 13D and 13G filings for Cyclacel Pharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2021-02-16
09:57 am
Purchase		 2020-12-31 13G Cyclacel Pharmaceuticals, Inc.
CYCC		 CVI Investments, Inc. 18,732
4.900%		 86increase
(+0.46%)		 Filing
2020-04-30
11:35 am
Purchase		 2020-04-21 13G Cyclacel Pharmaceuticals, Inc.
CYCC		 CVI Investments, Inc. 18,646
9.900%		 18,646increase
(New Position)		 Filing